论文部分内容阅读
目的探究前列地尔治疗高龄糖尿病并慢性肾脏病患者的临床效果和安全性。方法 82例高龄糖尿病并慢性肾脏病患者,随机分为观察组和对照组,各41例。观察组采用前列地尔进行治疗,对照组采用贝那普利进行治疗。对比两组临床效果。结果观察组患者的临床治疗总有效率为97.56%,高于对照组的73.17%;观察组患者的相关指标明显优于对照组,差异均有统计学意义(P<0.05)。结论对高龄糖尿病并慢性肾脏病患者采用前列地尔进行治疗,其治疗效果良好,能够有效缓解患者的病情,具有临床应用价值。
Objective To investigate the clinical efficacy and safety of alprostadil in the treatment of elderly patients with diabetes and chronic kidney disease. Methods 82 cases of elderly patients with diabetes and chronic kidney disease were randomly divided into observation group and control group, 41 cases each. The observation group was treated with alprostadil while the control group was treated with benazepril. Compare the clinical effect of two groups. Results The total effective rate of clinical observation in the observation group was 97.56%, which was higher than that in the control group (73.17%). The relevant indexes in the observation group were significantly better than those in the control group (P <0.05). Conclusion The treatment of elderly patients with diabetes mellitus and chronic kidney disease with alprostadil has good therapeutic effect, which can effectively relieve the patient’s disease and has clinical value.